Felipe Villacampa-Aubá

5PUBLICATIONS
16CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 28, 2026
Enhanced Endoscopic Imaging Technologies in Upper Urinary Tract Urothelial Tumors: Implications for Kidney-Sparing Surgery-A Narrative Review.

|Jun 26, 2026
BAP1 and PBRM1 Loss Is Associated with Aggressive Clinicopathological Features in Clear Cell Renal Cell Carcinoma: Prognostic Implications in a 10-Year Surgical Cohort.

|May 13, 2026
Diagnostic Role and Clinical Impact of Zr-Girentuximab PET-CT for the Diagnosis and Treatment of Clear-Cell Renal Cell Carcinoma.

|Nov 25, 2025
Immune Checkpoint Inhibitors for High-Risk Nonmuscle-Invasive Bladder Cancer: Lessons Learned From the CREST and POTOMAC Trials.

Daniel A González-Padilla, José Daniel Subiela, Felipe Villacampa-Aubá

|May 09, 2024
Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?

Daniel A González-Padilla, José Daniel Subiela, Felipe Villacampa-Aubá

Pageof 1

Frequent Collaborators

4 joint publications

José Daniel Subiela

3 joint publications

Daniel González-Padilla

3 joint publications

Daniel Sánchez-Zalabardo

3 joint publications

Bernardino Miñana-López